August 19, 2017 4:47 PM ET


Company Overview of GammaDelta Therapeutics Ltd.

Key Executives for GammaDelta Therapeutics Ltd.

NameBoard RelationshipsTitleAge
Paolo Paoletti M.D.36 RelationshipsChief Executive Officer66
Raj Mehta No RelationshipsFounder and Director of Intellectual Property--
Dayle Spencer Hogg DPhilNo RelationshipsChief Operating Officer--
Natalie Mount Ph.D.No RelationshipsChief Scientific Officer--

GammaDelta Therapeutics Ltd. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter Goodfellow Ph.D. 16 RelationshipsAbingworth LLP66
Timothy J. Haines BSc, MBA 48 RelationshipsAbingworth LLP59
View All Board Members

GammaDelta Therapeutics Ltd. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
GammaDelta Therapeutics Ltd. CEO Compensation
Industry Average


Cellectar Biosciences, Inc. Announces Management Changes
August 18, 2017 9:00 PM ET
Isofol Medical AB (publ) Appoints Sven Erickson as Chief Commercial Officer
August 18, 2017 6:32 PM ET
Kane Biotech Inc. Announces Resignation of Sarah Prichard as Director
August 18, 2017 11:12 AM ET
RHS Limited Appoints Alwin Hui as Chief Commercial Officer
August 18, 2017 3:43 AM ET
Immunocellular Therapeutics, Ltd. Announces Resignation of Mark A. Schlossberg and Gregg A. Lapointe from the Board of Directors
August 17, 2017 8:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GammaDelta Therapeutics Ltd., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at